SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027531
Filing Date
2021-05-13
Accepted
2021-05-13 16:06:33
Documents
70
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dbtx-10q_20210331.htm 10-Q 2525183
2 EX-31.1 dbtx-ex311_9.htm EX-31.1 19391
3 EX-31.2 dbtx-ex312_8.htm EX-31.2 19431
4 EX-32.1 dbtx-ex321_6.htm EX-32.1 9260
5 EX-32.2 dbtx-ex322_7.htm EX-32.2 9406
  Complete submission text file 0001564590-21-027531.txt   7944163

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dbtx-20210331.xml EX-101.INS 1709346
7 XBRL TAXONOMY EXTENSION SCHEMA dbtx-20210331.xsd EX-101.SCH 49349
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dbtx-20210331_cal.xml EX-101.CAL 38851
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbtx-20210331_def.xml EX-101.DEF 175507
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbtx-20210331_lab.xml EX-101.LAB 366724
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbtx-20210331_pre.xml EX-101.PRE 304785
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Filer) CIK: 0001656536 (see all company filings)

IRS No.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40030 | Film No.: 21919604
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences